118
Views
2
CrossRef citations to date
0
Altmetric
Preeclampsia

Newborn LpL (Ser447Stop, Asn291Ser) genotypes and the interaction with maternal genotypes influence the risk for different types of preeclampsia: modulating effect on lipid profile and pregnancy outcome

, , &
Pages 221-225 | Received 22 Mar 2013, Accepted 29 Nov 2013, Published online: 08 Jan 2014

References

  • Hubel CA, Kozlov AV, Kagan VE, et al. Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: implications for oxidative stress. Am J Obstet Gynecol 1996;175:692–700
  • Sattar N, Greer IA. Pregnancy complications and maternal risk: opportunities for intervention and screening? BMJ 2002;325:157–60
  • Garner PR, D'Alton ME, Dudley DK, et al. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990;163:505–8
  • Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996;335:226–32
  • Barden AE, Beilin LJ, Ritchie J, et al. Does a redisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertens 1999;17:1307–15
  • Davison JM, Homuth V, Jeyabalan A. New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol 2004;15:2440–8
  • Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet gynecol 2003;102:181–92
  • Roberts J, Redman C. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447–51
  • Dekker G, Sibai B. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359–75
  • Kaaja R. Lipid abnormalities in pre-eclampsia: implications for vascular health. Clin Lipidol 2011;6:71–8
  • Williams RR, Hunt SC, Hopkins PN, et al. Tabulations and expectations regarding the genetics of human hypertension. Kidney Int 1994;45:s57–64
  • Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 7th ed. New York: McGraw-Hill; 1995:1913–32
  • Humphries SE, Nicaud V, Margalef J, et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 1998;18:526–34
  • Wittekoek ME, Pimstone SN, Reymer PW, et al. A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia. Circulation 1998;97:729–35
  • Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familiar aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet 2004;130A:365–71
  • Kim YJ, Williamson RA, Chen K, et al. Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia. Hypertension 2001;38:992–6
  • Descamps OS, Bruniaux M, Guilmot PF, et al. Lipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn children. J Lipid Res 2005;46:2405–14
  • National High Blood Pressure Education Program (NHBPEP). Report of the National High Blood Preesure Education Program Working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1–22
  • Sing K, Ballantyne CM, Ferlic L, et al. Lipoprotein lipase gene mutations, plasma lipid levels, progression:regression of coronary atherosclerosis, response to therapy, and future clinical events Lipoproteins and Coronary Atherosclerosis Study. Atherosclerosis 1999;144:435–42
  • Oudejans CBM, van Dijk M, Osterkamp M, et al. Genetics of preeclampsia: paradigm shifts. Hum Genet 2007;120:607–12
  • Sattar N, Bendomir A, Berry C, et al. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997;89:403–8
  • Lorentzen B, Drevon CA, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and preeclamptic pregnancy. Br J Obstet Gynaecol 1995;102:530–7
  • Groenemeijer BE, Hallman MD, Reymer PW, et al. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 1997;95: 2628–35
  • Hokanson JE. Functional variants in the lipoprotein lipase gene and risk cardiovascular disease. Curr Opin Lipidol 1999;10:393–9
  • Atkinson KR, Blumenstein M, Black MA, et al. An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia. J Lipid Res 2009;50:71–80
  • Niu WQ, Qi Y. Meta-based association of the lipoprotein lipase gene S447X variant with hypertension and blood pressure variation. J Hum Hypertens 2011;25:383--90
  • Wittrup HH, Nordestgaard BG, Sillesen H, et al. A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men. Circulation 2000;101:2393–7
  • Zhang C, Austin MA, Edwards KL, et al. Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women. Clin Genet 2006;69:33–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.